Related Experiment Video
Updated: Aug 28, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
Effects of endocrine disrupting chemicals on the expression of RACK1 and LPS-induced THP-1 cell activation
Mirco Masi1, Ambra Maddalon2, Martina Iulini2
1Dipartimento di Scienze del Farmaco, Università Degli Studi di Pavia, Viale Taramelli 12/14, 27100 Pavia, Italy; Scuola Universitaria Superiore IUSS, Piazza della Vittoria 15, 27100 Pavia, Italy.
Abstract:
The existence of a complex hormonal balance among glucocorticoids, androgens and estrogens involved in the regulation of Receptor for Activated C Kinase 1 (RACK1) expression and its related immune cells activation, highlights the possibility to employ this protein as screening tool for the evaluation of the immunotoxic profile of endocrine disrupting chemicals (EDCs), hormone-active substances capable of interfering with the physiologic hormonal signaling. Hence, the aim of this work was to investigate the effect of the exposure of EDCS 17α-ethynylestradiol (EE), diethyl phthalate (DEP) and perfluorooctanesulfonic acid (PFOS) on RACK1 expression and on lipopolysaccharide (LPS)-induced activation of the human monocytic cell line THP-1, a validated model for this investigation. In line with our previous results with estrogen-active compounds, EE treatment significantly induced RACK1 promoter transcriptional activity, mRNA expression, and protein levels, which paralleled an increase in LPS-induced IL-8, TNF-α production and CD86 expression, previously demonstrated to be dependent on RACK1/PKCβ activation. EE mediates its effect on RACK1 expression through G-protein-coupled estrogen receptor (GPER) and androgen receptor (AR) ligand-independent cascade, as also suggested by in silico molecular docking simulation. Conversely, DEP and PFOS induced a dose-dependent downregulation of RACK1 promoter transcriptional activity, mRNA expression, and protein levels, which was mirrored by a reduction of IL-8, TNF-α production and CD86 expression. Mifepristone pre-treatments abolish DEP and PFOS effects, confirming their GR agonist profile, also corroborated by molecular docking. Altogether, our data confirm that RACK1 represents an interesting target of steroid active compounds, which expression offers the opportunity to screen the immunotoxic potential of different hormone-active substances of concerns due to their human exposure and environmental persistence.
Insights
Receptor for Activated C Kinase 1 (RACK1) expression is modulated by endocrine disrupting chemicals (EDCs). RACK1 can serve as a screening tool to assess the immunotoxicity of EDCs like EE, DEP, and PFOS.
Area of Science:
- Endocrinology
- Immunotoxicology
- Molecular Biology
Background:
- Hormonal balance regulates Receptor for Activated C Kinase 1 (RACK1) expression and immune cell activation.
- Endocrine disrupting chemicals (EDCs) interfere with hormonal signaling.
- RACK1's role in immune response suggests its potential as a biomarker for EDC immunotoxicity.
Purpose of the Study:
- To investigate the effects of EDCs 17α-ethynylestradiol (EE), diethyl phthalate (DEP), and perfluorooctanesulfonic acid (PFOS) on RACK1 expression.
- To evaluate the impact of these EDCs on lipopolysaccharide (LPS)-induced activation of THP-1 cells.
- To explore RACK1 as a screening tool for EDC immunotoxicity.
Main Methods:
- Exposure of human monocytic THP-1 cells to EE, DEP, and PFOS.
- Measurement of RACK1 promoter activity, mRNA, and protein levels.
- Assessment of LPS-induced IL-8, TNF-α production, and CD86 expression.
- In silico molecular docking simulations and mifepristone pre-treatments.
Main Results:
- EE significantly induced RACK1 expression and LPS-induced immune responses via GPER and AR.
- DEP and PFOS dose-dependently downregulated RACK1 expression and immune responses.
- Mifepristone pre-treatment abolished DEP and PFOS effects, indicating a glucocorticoid receptor (GR) agonist profile.
Conclusions:
- RACK1 expression is a sensitive indicator of hormone-active compound exposure.
- RACK1 modulation by EDCs affects immune cell activation.
- RACK1 serves as a valuable target for screening the immunotoxic potential of environmental hormone-active substances.
More Related Videos
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

